Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

491 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial.
Arai H, Yamashita S, Yokote K, Araki E, Suganami H, Ishibashi S; K-877 Study Group. Arai H, et al. Among authors: yokote k. J Atheroscler Thromb. 2018 Jun 1;25(6):521-538. doi: 10.5551/jat.44412. Epub 2018 Apr 7. J Atheroscler Thromb. 2018. PMID: 29628483 Free PMC article. Clinical Trial.
Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study).
Yokote K, Bujo H, Hanaoka H, Shinomiya M, Mikami K, Miyashita Y, Nishikawa T, Kodama T, Tada N, Saito Y. Yokote K, et al. Atherosclerosis. 2008 Dec;201(2):345-52. doi: 10.1016/j.atherosclerosis.2008.02.008. Epub 2008 Feb 16. Atherosclerosis. 2008. PMID: 18472103 Clinical Trial.
Guidelines for the management of familial hypercholesterolemia.
Harada-Shiba M, Arai H, Oikawa S, Ohta T, Okada T, Okamura T, Nohara A, Bujo H, Yokote K, Wakatsuki A, Ishibashi S, Yamashita S. Harada-Shiba M, et al. Among authors: yokote k. J Atheroscler Thromb. 2012;19(12):1043-60. doi: 10.5551/jat.14621. Epub 2012 Oct 25. J Atheroscler Thromb. 2012. PMID: 23095242 Free article.
Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications Study.
Kawasaki R, Tanaka S, Tanaka S, Abe S, Sone H, Yokote K, Ishibashi S, Katayama S, Ohashi Y, Akanuma Y, Yamada N, Yamashita H; Japan Diabetes Complications Study Group. Kawasaki R, et al. Among authors: yokote k. Ophthalmology. 2013 Mar;120(3):574-582. doi: 10.1016/j.ophtha.2012.08.029. Epub 2012 Nov 20. Ophthalmology. 2013. PMID: 23174397
Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K; Japan Atherosclerosis Society. Teramoto T, et al. Among authors: yokote k. J Atheroscler Thromb. 2013;20(6):517-23. doi: 10.5551/jat.15792. Epub 2013 May 11. J Atheroscler Thromb. 2013. PMID: 23665881 Free article. No abstract available.
Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K; Japan Atherosclerosis Society (JAS). Teramoto T, et al. Among authors: yokote k. J Atheroscler Thromb. 2013;20(7):603-15. doi: 10.5551/jat.15867. Epub 2013 Jul 25. J Atheroscler Thromb. 2013. PMID: 23883545 Free article. No abstract available.
Diagnostic criteria for dyslipidemia.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K. Teramoto T, et al. Among authors: yokote k. J Atheroscler Thromb. 2013;20(8):655-60. doi: 10.5551/jat.17152. Epub 2013 Jul 26. J Atheroscler Thromb. 2013. PMID: 23892528 Free article. No abstract available.
Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K. Teramoto T, et al. Among authors: yokote k. J Atheroscler Thromb. 2013;20(10):733-42. doi: 10.5551/jat.17368. Epub 2013 Jul 26. J Atheroscler Thromb. 2013. PMID: 23892529 Free article. No abstract available.
Absolute risk of cardiovascular disease and lipid management targets.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K. Teramoto T, et al. Among authors: yokote k. J Atheroscler Thromb. 2013;20(9):689-97. doi: 10.5551/jat.17392. Epub 2013 Jul 26. J Atheroscler Thromb. 2013. PMID: 23892530 Free article. No abstract available.
491 results